wsbdaily | Tue, 20 Dec 2022 03:11:26 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Moderna, Inc.(MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus... Read More
Summary & Charts
| Price | $ 189.89 | -3.40 (-1.76%) |
| Day's Range | $ 187.87 - 204.00 | |
| Previous Close | $ 193.29 | |
| Market Cap | $ 79.62B USD | |
| Short Interest % | 4.99 % | As of Fri, 14 Jan 2022 |
| Float | 334.09M | |
| Outstanding | 384.18M |
| Exchange | NasdaqGS | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 6.60M | |
| Avg. Volume (20 day) | 6.30M | |
| Rel. Volume (20 day) | 1.05 | |
| Rel. Volume (3 month) | 1.24 | |
| Rating | A+ | Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 44.82 % | Neutral |
| ROE | 70.03 % | Neutral |
| ROA | 45.15 % | Neutral |
| P/E | 7.28 % | Strong Buy |
| P/B | 4.09 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | $ 200.00 | $ 204.00 | $ 187.87 | $ 189.89 | -3.40 | 6,599,709 | 1.05 | 1.24 | 7 |
| Dec 16, 2022 | $ 206.37 | $ 209.85 | $ 190.62 | $ 193.29 | -13.96 | 11,811,549 | 1.92 | 2.18 | 11 |
| Dec 15, 2022 | $ 207.61 | $ 212.44 | $ 202.09 | $ 207.25 | -1.70 | 9,641,915 | 1.68 | 1.80 | 7 |
| Dec 14, 2022 | $ 195.08 | $ 217.25 | $ 192.54 | $ 208.95 | +11.41 | 21,419,489 | 3.93 | 4.08 | 41 |
| Dec 13, 2022 | $ 187.33 | $ 208.52 | $ 184.02 | $ 197.54 | +32.41 | 26,135,689 | 5.64 | 5.24 | 46 |
| Dec 12, 2022 | $ 175.53 | $ 175.77 | $ 162.78 | $ 165.13 | -12.22 | 5,200,741 | 1.42 | 1.11 | 3 |
| Dec 09, 2022 | $ 185.00 | $ 185.09 | $ 177.10 | $ 177.35 | -7.35 | 3,498,033 | 0.98 | 0.74 | |
| Dec 08, 2022 | $ 179.12 | $ 185.21 | $ 177.52 | $ 184.70 | +5.70 | 3,412,028 | 0.94 | 0.73 | 1 |
| Dec 07, 2022 | $ 172.31 | $ 180.38 | $ 171.85 | $ 179.00 | +5.46 | 3,576,827 | 0.98 | 0.76 | |
| Dec 06, 2022 | $ 175.02 | $ 175.78 | $ 169.70 | $ 173.54 | -2.39 | 3,391,445 | 0.93 | 0.73 | 5 |
| Dec 05, 2022 | $ 180.99 | $ 183.69 | $ 173.59 | $ 175.93 | -6.42 | 3,523,734 | 0.95 | 0.75 | 1 |
| Dec 02, 2022 | $ 178.50 | $ 182.78 | $ 177.00 | $ 182.35 | +0.87 | 2,765,533 | 0.70 | 0.59 | |
| Dec 01, 2022 | $ 173.41 | $ 185.90 | $ 172.50 | $ 181.48 | +5.57 | 4,871,454 | 1.14 | 1.03 | |
| Nov 30, 2022 | $ 173.52 | $ 176.75 | $ 169.06 | $ 175.91 | +2.76 | 3,720,457 | 0.87 | 0.79 | |
| Nov 29, 2022 | $ 176.15 | $ 179.00 | $ 171.53 | $ 173.15 | -2.23 | 2,837,592 | 0.66 | 0.60 | 1 |
| Nov 28, 2022 | $ 177.09 | $ 184.21 | $ 174.67 | $ 175.38 | -1.02 | 3,748,256 | 0.86 | 0.79 | 5 |
| Nov 25, 2022 | $ 175.01 | $ 179.14 | $ 173.41 | $ 176.40 | -0.41 | 1,221,243 | 0.28 | 0.26 | 1 |
| Nov 23, 2022 | $ 178.01 | $ 179.36 | $ 174.58 | $ 176.81 | -2.78 | 2,308,719 | 0.51 | 0.48 | 2 |
| Nov 22, 2022 | $ 176.08 | $ 179.83 | $ 170.27 | $ 179.59 | +2.84 | 3,305,845 | 0.71 | 0.68 | 1 |
| Nov 21, 2022 | $ 179.71 | $ 180.79 | $ 175.17 | $ 176.75 | -4.84 | 3,099,114 | 0.65 | 0.63 | 2 |
News
The latest news about Moderna, Inc. (MRNA).
The Motley Fool | 2022-12-18 09:15:00
Moderna and Merck are up on the news regarding their melanoma cancer vaccine.
The Motley Fool | 2022-12-18 05:15:00
These stocks are dirt cheap today. But low valuations may not last for long.
The Motley Fool | 2022-12-17 09:15:00
These stocks could have significant upside opportunities ahead.
The Motley Fool | 2022-12-17 06:33:00
Here are some great bargains for long-term investors as we approach the end of the year.
Seeking Alpha | 2022-12-16 16:00:00
Keytruda has proved to be MRK's leading sales driver, projected to contribute a significant 35.38% of FY2022 revenues at $20.9B. Given the early clinical success of MRNA and Keytruda combo, we reckon the former has a similarly bright prospect through the next decade, aided by the flu and RSV vaccines.
Seeking Alpha | 2022-12-16 13:50:38
Moderna, Inc. lauded results from a clinical study readout. The large magnitude of the positive trend in a deadly cancer is an encouraging sign.
Forbes | 2022-12-15 05:00:37
Moderna stock rallied by close to 20% in Tuesday's trading, after it announced positive results from mid-stage trials for a messenger RNA-based vaccine for skin cancer patients that it is developing with Merck.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | BMO | 3.29 | 2.53 | -23.11% | -- | -- | -- |
| 2022-08-03 | BMO | 4.55 | 5.24 | 15.16% | -- | -- | -- |
| 2022-05-04 | BMO | 5.21 | 8.58 | 64.68% | 5.3B | 6.1B | 14.4% |
| 2022-02-24 | BMO | 9.9 | 11.29 | 14.04% | 6B | 7.2B | 20.59% |
| 2021-11-04 | BMO | 8.96 | 7.70 | -14.07% | 6.4B | 5B | -22.92% |
| 2021-08-05 | BMO | 6.01 | 6.46 | 7.48% | 4.2B | 4.4B | 3.48% |
| 2021-05-06 | BMO | 2.39 | 2.84 | 18.82% | 2.4B | 1.9B | -19.77% |
| 2021-02-25 | BMO | -0.35 | -0.69 | 97.14% | 460M | 0.6B | 24.14% |
Top Discussions
These are the top discussions over the last 24-hours that mention the MRNA stock ticker symbol.
Daily Discussion Thread for December 19, 2022
**Watch WallStreetBets discuss markets on[](https://twitter.com/Official_WSB) [YouTube](https://www.youtube.com/channel/UCRPCE1kzX-JHzcAHfPSs87Q?sub_confirmation=1)** Follow [Twitter](https://twitter... Read More
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| CALL | $ 207.50 | 12/15/22 | 0 | $ 2.90 | $ 3.25 | $ 3.10 | 1,393 | 624 | 2.23 | 0.74% |
| CALL | $ 210.00 | 12/15/22 | 0 | $ 2.03 | $ 2.28 | $ 2.14 | 8,482 | 4,049 | 2.09 | 0.77% |
| CALL | $ 212.50 | 12/15/22 | 0 | $ 1.25 | $ 1.50 | $ 1.40 | 2,681 | 1,748 | 1.53 | 0.77% |
| CALL | $ 215.00 | 12/15/22 | 0 | $ 0.83 | $ 0.95 | $ 0.81 | 9,720 | 2,207 | 4.40 | 0.79% |
| PUT | $ 195.00 | 12/15/22 | 0 | $ 0.22 | $ 0.49 | $ 0.22 | 2,164 | 1,662 | 1.30 | 0.85% |
| PUT | $ 197.50 | 12/15/22 | 0 | $ 0.42 | $ 0.48 | $ 0.44 | 4,639 | 1,349 | 3.44 | 0.76% |
| PUT | $ 200.00 | 12/15/22 | 0 | $ 0.72 | $ 0.83 | $ 0.78 | 5,470 | 3,170 | 1.73 | 0.74% |
| PUT | $ 207.50 | 12/15/22 | 0 | $ 3.10 | $ 3.55 | $ 3.35 | 1,009 | 308 | 3.28 | 0.74% |
| CALL | $ 215.00 | 12/22/22 | 6 | $ 4.30 | $ 4.60 | $ 4.50 | 862 | 463 | 1.86 | 0.62% |
| CALL | $ 220.00 | 12/22/22 | 6 | $ 2.84 | $ 3.20 | $ 2.84 | 1,754 | 656 | 2.67 | 0.62% |
| CALL | $ 225.00 | 12/22/22 | 6 | $ 2.00 | $ 2.30 | $ 2.17 | 661 | 502 | 1.32 | 0.64% |
| PUT | $ 187.50 | 12/22/22 | 6 | $ 1.18 | $ 1.31 | $ 1.25 | 155 | 71 | 2.18 | 0.62% |
| PUT | $ 192.50 | 12/22/22 | 6 | $ 1.91 | $ 2.11 | $ 2.07 | 291 | 113 | 2.58 | 0.60% |
| PUT | $ 200.00 | 12/22/22 | 6 | $ 4.05 | $ 4.20 | $ 4.14 | 819 | 498 | 1.64 | 0.60% |
| CALL | $ 225.00 | 12/29/22 | 13 | $ 3.50 | $ 4.00 | $ 3.75 | 297 | 130 | 2.28 | 0.59% |
| PUT | $ 182.50 | 12/29/22 | 13 | $ 1.54 | $ 1.79 | $ 1.83 | 155 | 116 | 1.34 | 0.58% |
| PUT | $ 210.00 | 12/29/22 | 13 | $ 10.65 | $ 11.05 | $ 11.50 | 327 | 139 | 2.35 | 0.56% |
| PUT | $ 220.00 | 12/29/22 | 13 | $ 17.05 | $ 17.60 | $ 17.27 | 40 | 16 | 2.50 | 0.56% |
| PUT | $ 130.00 | 01/05/23 | 20 | $ 0.02 | $ 0.29 | $ 0.20 | 30 | 17 | 1.76 | 0.85% |
| CALL | $ 225.00 | 01/12/23 | 27 | $ 7.35 | $ 8.50 | $ 7.80 | 560 | 267 | 2.10 | 0.63% |
| PUT | $ 210.00 | 01/12/23 | 27 | $ 14.75 | $ 16.10 | $ 16.27 | 32 | 18 | 1.78 | 0.60% |
| PUT | $ 400.00 | 01/19/23 | 34 | $ 190.95 | $ 195.00 | $ 189.31 | 29 | 14 | 2.07 | 0.88% |
| CALL | $ 170.00 | 01/26/23 | 41 | $ 41.35 | $ 42.90 | $ 39.03 | 182 | 13 | 14.00 | 0.68% |
| PUT | $ 240.00 | 03/16/23 | 90 | $ 45.00 | $ 46.10 | $ 47.45 | 29 | 20 | 1.45 | 0.58% |
| PUT | $ 60.00 | 04/20/23 | 125 | $ 0.20 | $ 0.34 | $ 0.27 | 242 | 114 | 2.12 | 0.94% |
| PUT | $ 220.00 | 04/20/23 | 125 | $ 35.50 | $ 36.45 | $ 36.35 | 59 | 41 | 1.44 | 0.58% |
| PUT | $ 240.00 | 04/20/23 | 125 | $ 48.40 | $ 49.25 | $ 51.00 | 41 | 24 | 1.71 | 0.57% |
| CALL | $ 230.00 | 06/15/23 | 181 | $ 29.50 | $ 30.25 | $ 29.05 | 579 | 388 | 1.49 | 0.66% |
| PUT | $ 90.00 | 07/20/23 | 216 | $ 2.46 | $ 3.05 | $ 2.72 | 480 | 167 | 2.87 | 0.76% |
| PUT | $ 260.00 | 01/18/24 | 398 | $ 78.10 | $ 80.20 | $ 80.15 | 338 | 196 | 1.72 | 0.50% |
| CALL | $ 240.00 | 01/16/25 | 762 | $ 60.25 | $ 66.05 | $ 60.77 | 40 | 21 | 1.90 | 0.63% |
| PUT | $ 135.00 | 01/16/25 | 762 | $ 22.40 | $ 26.70 | $ 24.50 | 80 | 30 | 2.67 | 0.56% |
Last Updated: Thu, 15 Dec 2022 22:07 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 14 Dec 2021 12:00 EST
@wsbdaily
wsbdaily